SCHEMBL13744561

SCHEMBL13744561

Cc1ccc(NC(=O)c2oc3ccc(C(=O)N(C)C)cc3c2NC(=O)[C@H]2CC[C@H](N(C)C)CC2)nc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 3/20 0.45
▸ RAB9A P51151 3/20 0.45
▸ KMT2A Q03164 5/20 0.45
▸ CASP3 P42574 1/20 0.45
▸ SENP7 Q9BQF6 1/20 0.45
▸ SENP6 Q9GZR1 1/20 0.45
▸ MAPT P10636 4/20 0.43
▸ TP53 P04637 1/20 0.43
▸ GSK3B P49841 3/20 0.42
▸ DYRK1A Q13627 3/20 0.42
▸ WNT1 P04628 1/20 0.42
▸ MEN1 O00255 4/20 0.41
▸ GCK P35557 2/20 0.40
▸ HSD17B10 Q99714 3/20 0.39
▸ TSHR P16473 2/20 0.39
▸ NPSR1 Q6W5P4 2/20 0.39
▸ SMN1; SMN2 Q16637 2/20 0.39
▸ LMNA P02545 1/20 0.39
▸ DHODH Q02127 1/20 0.39
▸ ALDH1A1 P00352 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13665082 0.93 NPC1 (0.46) NPC1RAB9AKMT2ACASP3SENP7
SCHEMBL13863934 0.93 NPC1 (0.46) NPC1RAB9AKMT2ACASP3SENP7
SCHEMBL13744274 0.91 NPC1 (0.49) NPC1RAB9AKMT2ACASP3SENP7
SCHEMBL13744498 0.90 NPC1 (0.48) NPC1RAB9AKMT2ACASP3SENP7
SCHEMBL13744373 0.89 NPC1 (0.44) NPC1RAB9AKMT2ACASP3SENP7
SCHEMBL13744689 0.86 KMT2A (0.59) NPC1RAB9AKMT2ACASP3SENP7
SCHEMBL13665080 0.86 NPC1 (0.46) NPC1RAB9AKMT2ACASP3SENP7
SCHEMBL13665078 0.85 NPC1 (0.49) NPC1RAB9AKMT2ACASP3SENP7
SCHEMBL13665087 0.84 NPC1 (0.42) NPC1RAB9AKMT2ACASP3SENP7
SCHEMBL4325368 0.84 SMN1; SMN2 (0.46) NPC1RAB9AKMT2AMAPTTP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090209511-A1 Benzofuran Derivatives KAWAGUCHI TAKAYUKI 2009-08-20 — — US disclosed
US-20090209511-A1 Benzofuran Derivatives KAWAGUCHI TAKAYUKI 2009-08-20 — — US disclosed
US-7531537-B2 Benzofuran derivative MITSUBISHI TANABE PHARMA CORPORATION (JP) 2009-05-12 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090209511-A1 Benzofuran Derivatives F12, F2, F3 NPC1 3431/4885RAB9A 4600/4885KMT2A 1518/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback